Audited Supplier
In This Store
We focus on synthetic biology technology research and development and industrial application, with "from nature, for nature" as the core concept, to build a full chain system from molecular design to large-scale production. Relying on core technologies such as enzyme engineering, gene editing, and cell fermentation, the company develops products such as microbial drug raw materials, biological pesticides, and food additives to help the low-carbon transformation of medicine, agriculture, and chemical industries.
Year of Establishment: 2022
Total Assets(USD): 500,000 to 99,999,999
Total Number of Staff: 10-50
Main Competitive Advantages: Brand Name,International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Reputation,Quality Service
Other Competitive Advantages: Unique Technology: "Reverse" genetic modification and "glycolysis" enzyme libraries accelerate the creation and transformation of chassis organisms Industry Leading: Compared with the industry, we have a "0" enzyme catalytic cost, and the yield and industrial scale far exceed those of our peers, and the unit cost is greatly reduced.
Patents and Copyrights: At present, we have over 20 types of invention patents on public display. If you need to check the details, please search by yourself.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094
Follow Us：
Pharma Sources Insight January 2025
